(±)-Chlorpheniramine maleate salt
SIGMA/C3025 - ≥99% (perchloric acid titration)
CAS Number: 113-92-8
Empirical Formula (Hill Notation): C16H19ClN2 · C4H4O4
Molecular Weight: 390.86
EC Number: 204-037-5
MDL Number: MFCD00069225
Linear Formula: C16H19ClN2 · C4H4O4
Product Type: Chemical
| assay | ≥99% (perchloric acid titration) |
| form | powder |
| InChI | 1S/C16H19ClN2.C4H4O4/c1-1 |
| InChI key | DBAKFASWICGISY-BTJKTKAUSA |
| mp | 130-135 °C (lit.) |
| originator | Bayer |
| Quality Level | 100 ![]() |
| SMILES string | CN(C)CCC(C1=CC=C(Cl)C=C1) |
| Application: | (±)-Chlorpheniramine maleate salt has been used: • as H1 receptor antagonist to determine the receptor function • to block the effect of compound 48/80 on plasma IGF-I • as a standard for fast sensing and determination by sequential injector coupled with potentiometer |
| Biochem/physiol Actions: | Chlorpheniramine maleate (CPM) can prevent rhinitis and urticaria. It is used to cure several allergic conditions. This antihistamine is used in small-animal veterinary practices. |
| Biochem/physiol Actions: | H1 Histamine receptor antagonist. |
| Features and Benefits: | This compound was developed by Bayer . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: | Chlorpheniramine maleate (CPM)/(3-(4-chlorophenyl) |
| Packaging: | 5, 25, 100 g in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P301 + P312 + P330 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥99% (perchloric acid titration) |
| mp | 130-135 °C (lit.) |
| UNSPSC | 12352116 |


